Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Rovi falls after cutting 2026 operating revenue outlook

** Shares of Rovi ROVI.MC fall 13.5% after lowering its 2026 operating revenue growth guidance

** The Spanish pharma company now expects 2026 revenue to grow at a low- to mid-single-digit rate vs previous guidance for high single-digit to low double-digit growth

** Renta4 expects a negative reaction to the guidance downgrade, which compares to its 8.6% growth forecast for Rovi's 2026 operating revenue

** Shares are the top fallers on Madrid's blue-chip IBEX 35 .IBEX and on track for their biggest daily drop since Feb 2025

 (Reporting by Joao Manuel Mauricio)

 ((JoaoManuel.VicenteMauricio@thomsonreueters.com))

Recent news on Laboratorios Farmaceuticos Rovi

See all news